参考文献/References:
[1] 中国心血管健康与疾病报告2022概要[J]. 中国循环杂志,2023,38(6):583-612.
[2] 刘颂,王萌,管文贤. 蛋白相分离的相关研究进展[J]. 中华普外科手术学杂志(电子版),2019,13(4):430-432.
[3] Bosco,DA,Lemay,et al. Mutant FUS proteins that cause amyotrophic lateral sclerosis incorporate into stress granules[J]. Hum Mol Genet,2010,19(21):4160-4175.
[4] Ren J,Zhang Z,Zong Z,et al. Emerging implications of phase separation in cancer[J]. Adv Sci (Weinh),2022,9(31):e2202855.
[5] Brangwynne CP,Eckmann CR,Courson DS,et al. Germline P granules are liquid droplets that localize by controlled dissolution/condensation[J]. Science,2009,324(5935):1729-1732.
[6] 吴荣波,李丕龙. 液-液相分离与生物分子凝集体[J]. 科学通报,2019,64(22):2285-2291.
[7] Banjade S,Rosen MK. Phase transitions of multivalent proteins can promote clustering of membrane receptors[J]. E Life,2014,3:e04123.
[8] Dolgin E. What lava lamps and vinaigrette can teach us about cell biology[J]. Nature,2018,555(7696):300-302.
[9] Romero P,Obradovic Z,Li X,et al. Sequence complexity of disordered protein[J]. Proteins,2001,42(1):38-48.
[10] Vucetic S,Brown CJ,Dunker AK,et al. Flavors of protein disorder[J]. Proteins,2003,52(4):573-584.
[11] Vernon RM,Chong PA,Tsang B,et al. Pi-Pi contacts are an overlooked protein feature relevant to phase separation[J]. Elife ,2018,7:e31486.
[12] Mo Y,Feng Y,Huang W,et al. Liquid–liquid phase separation in cardiovascular diseases[J]. Cells,2022,11(19):3040.
[13] Shin Y,Brangwynne CP. Liquid phase condensation in cell physiology and disease[J]. Science,2017,357(6357):eaaf4382.
[14] Cai Z,Mei S,Zhou L,et al. Liquid-liquid phase separation sheds new light upon cardiovascular diseases[J]. Int J Mol Sci,2023,24(20):15418.
[15] Hyman AA,Weber CA,Jülicher F. Liquid-liquid phase separa tion in biology[J]. Annu Rev Cell Dev Biol,2014,30:39-58.
[16] 李惠,刘庆喜,李新军等. 细胞内生物大分子的相分离研究进展[J]. 生物工程学报,2020,36(7):1261-1268.
[17] Zhang H,Ji X,Li P,et al. Liquid-liquid phase separation in biology:mechanisms,physiological functions and human diseases[J]. Sci China Life Sci,2020,63(7):953-985.
[18] 勾泓荃,卞知玄,孙奋勇. 相分离视角下的应激颗粒研究进展[J]. 同济大学学报(医学版),2022,43(5):603-610.
[19] Brangwynne CP. Phase transitions and size scaling of membrane-less organelles[J]. J Cell Biol,2013,203(6):875-881.
[20] Boija A,Klein IA,Sabari BR,et al. Transcription factors activate genes through the phase-separation capacity of their activation domains[J]. Cell,2018,175(7):1842-1855.
[21] Sabari BR,Dall’Agnese A,Boija A,et al. Coactivator condensation at super-enhancers links phase separation and gene control[J]. Science,2018,361(6400):eaar3958.
[22] Su X,Ditlev JA,Hui E,et al. Phase separation of signaling molecules promotes T cell receptor signal transduction[J]. Science,2016,352(6285):595-599.
[23] Jiang Y,Lei G,Lin T,et al. 1,6-Hexanediol regulates angiogenesis via suppression of cyclin A1-mediated endothelial function[J]. BMC Biol,2023,21(1):75.
[24] Liu J,Wang J,Liu Y,et al. Liquid-liquid phase separation of DDR1 counteracts the Hippo pathway to orchestrate arterial stiffening[J]. Circ Res,2023,132(1):87-105.
[25] Zhang L,Chen Q,An W,et al. Novel pathological role of hnRNPA1 (heterogeneous nuclear ribonucleoprotein A1) in vascular smooth muscle cell function and neointima hyperplasia[J]. Arterioscler Thromb Vasc Biol,2017,37(11):2182-2194.
[26] Molliex A,Temirov J,Lee J,et al. Phase separation by low complexity domains promotes stress granule assembly and drives pathological fibrillization[J]. Cell,2015,163(1):123-133.
[27] Chen D,Wang Z,Zhao YG,et al. Inositol polyphosphate multikinase inhibits liquid-liquid phase separation of TFEB to negatively regulate autophagy activity[J]. Dev Cell,2020,55(5):588-602.
[28] Li X,Zhu R,Jiang H,et al. Autophagy enhanced by curcumin ameliorates inflammation in atherogenesis via the TFEB-P300-BRD4 axis[J]. Acta Pharm Sin B,2022,12(5):2280-2299.
[29] Horii Y,Matsuda S,Toyota C,et al. VGLL3 is a mechanosensitive protein that promotes cardiac fibrosis through liquid-liquid phase separation[J]. Nat Commun,2023,14(1):550.
[30] Spitler KM,Ponce JM,Oudit GY,et al. Cardiac Med1 deletion promotes early lethality, cardiac remodeling, and transcriptional reprogramming[J]. Am J Physiol Heart Circ Physiol,2017,312(4):H768-H780.
[31] Song S,Liu L,Yu Y,et al. Inhibition of BRD4 attenuates transverse aortic constriction- and TGF-β-induced endothelial-mesenchymal transition and cardiac fibrosis[J]. J Mol Cell Cardiol,2019,127:83-96.
[32] Reichart D,Magnussen C,Zeller T,et al. Dilated cardiomyopathy:From epidemiologic to genetic phenotypes:Atranslational review of current literature[J]. J Intern Med,2019,286(4):362-372.
[33] Schneider JW,Oommen S,Qureshi MY,et al. Dysregulated ribonucleoprotein granules promote cardiomyopathy in RBM20 gene-edited pigs[J]. Nat Med,2020,26(11):1788-1800.
[34] Xie S,Chen M,Fang W,et al. Diminished arachidonate 5-lipoxygenase perturbs phase separation and transcriptional response of Runx2 to reverse pathological ventricular remodeling[J]. EBioMedicine,2022,86:104359.
[35] Protter DSW,Parker R. Principles and properties of stress granules[J]. Trends in Cell Biology,2016,26(9):668-679.
[36] Dong G,Liang F,Sun B,et al. Presence and function of stress granules in atrial fibrillation[J]. PLoS One,2019,14(4):e0213769.
相似文献/References:
[1]白春兰,张军.正五聚蛋白-3:新型心血管病炎性标志物[J].心血管病学进展,2016,(1):87.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.023]
BAI Chunlan,ZHANG Jun.Pentraxin-3: A Novel Inflammation Biomarker for Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2016,(7):87.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.023]
[2]任茂佳,贺文帅,张琪,等.围绝经期对心血管疾病相关危险因素的影响[J].心血管病学进展,2019,(6):911.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.018]
REN Maojia,HE Wenshuai,ZHANG Qi,et al.Effects of Perimenopause on Cardiovascular Risk Factors[J].Advances in Cardiovascular Diseases,2019,(7):911.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.018]
[3]尹琳 黄从新.JP2蛋白和心血管疾病的研究进展[J].心血管病学进展,2019,(7):1004.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.010]
YIN Lin HUANG Congxin.Research Progress of JP2 Protein and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2019,(7):1004.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.010]
[4]朱峰 汪汉 蔡琳.抗体与心血管疾病[J].心血管病学进展,2019,(7):1007.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.011]
ZHU FengWANG HanCAI Lin.Antibodies and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2019,(7):1007.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.011]
[5]邱明仙 王正龙 许官学.心肌肌球蛋白结合蛋白-C磷酸化与心血管疾病关系的研究进展[J].心血管病学进展,2019,(7):1015.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.013]
QIU MingxianWANG ZhenglongXU Guanxue.Research Progress of the Relationship Between Cardiac Myosin Binding Protein-C and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2019,(7):1015.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.013]
[6]姬楠楠 杨晓静 谢勇.单核细胞/高密度脂蛋白比值与心血管疾病的研究进展[J].心血管病学进展,2019,(7):1019.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.014]
JI Nannan YANG Xiaojing XIE Yong.Monocyte/High-density Lipoprotein Ratio and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2019,(7):1019.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.014]
[7]渠海贤 李涛 程流泉.人工智能在心脏磁共振成像中的应用进展[J].心血管病学进展,2019,(5):659.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.001]
[8]侯冬华 郝丽荣.长正五聚蛋白3在动脉粥样硬化和心血管疾病中作用研究的新进展[J].心血管病学进展,2019,(5):805.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.035]
HOU Donghua H AO Lirong.The Study of Atherosclerosis and Cardiovascular Diseases with Pentapycin 3[J].Advances in Cardiovascular Diseases,2019,(7):805.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.035]
[9]张维 张恒 康品方.外泌体在心血管疾病中的研究进展[J].心血管病学进展,2019,(5):818.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.038]
Zhang WeiKang Pinfang.Exosome in Cardiovascular Diseases[J].Advances in Cardiovascular Diseases,2019,(7):818.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.038]
[10]韦莹 刘书旺 李蕾 崔鸣.生长分化因子-15在心房颤动中的研究进展[J].心血管病学进展,2019,(8):1073.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.001]
WEI Ying,LIU Shuwang,LI Lei,et al.Growth Differentiation Factor-15 in Development of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2019,(7):1073.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.001]